Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
  1. Chemocentryx

    World Rank (Aug-2026)
    9,478
    Market Cap (Aug-2026)
    0.951 Billion USD
    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -131 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
  2. Riverstone Holdings Limited

    World Rank (Aug-2026)
    9,499
    Market Cap (Aug-2026)
    0.945 Billion USD
    World Rank (Jan-05-2024)
    9,852
    Market Cap (Jan-05-2024)
    0.789 Billion USD
    World Rank (Jul-30-2023)
    10,721
    Market Cap (Jul-30-2023)
    0.696 Billion USD
    World Rank (Dec-25-2022)
    10,338
    Market Cap (Dec-25-2022)
    0.702 Billion USD
    World Rank (Jan-07-2022)
    10,636
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Annual Revenue in USD
    728 Million USD
    Annual Net Income in USD
    335 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. Geron Corporation

    World Rank (Aug-2026)
    9,506
    Market Cap (Aug-2026)
    0.944 Billion USD
    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -138 Million USD
    Annual Net Income in USD
    -141 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

  4. Guangxi Wuzhou Zhongheng Group

    World Rank (Aug-2026)
    9,508
    Market Cap (Aug-2026)
    0.943 Billion USD
    World Rank (Jan-05-2024)
    7,655
    Market Cap (Jan-05-2024)
    1.217 Billion USD
    World Rank (Jul-30-2023)
    7,716
    Market Cap (Jul-30-2023)
    1.231 Billion USD
    World Rank (Dec-25-2022)
    7,095
    Market Cap (Dec-25-2022)
    1.328 Billion USD
    World Rank (Jan-07-2022)
    6,105
    Market Cap (Jan-07-2022)
    2.10 Billion USD
    Headquarters Country
  5. Mochida Pharmaceutical

    World Rank (Aug-2026)
    9,510
    Market Cap (Aug-2026)
    0.943 Billion USD
    World Rank (Jan-05-2024)
    9,714
    Market Cap (Jan-05-2024)
    0.811 Billion USD
    World Rank (Jul-30-2023)
    9,555
    Market Cap (Jul-30-2023)
    0.853 Billion USD
    World Rank (Dec-25-2022)
    8,617
    Market Cap (Dec-25-2022)
    0.953 Billion USD
    World Rank (Jan-07-2022)
    8,775
    Market Cap (Jan-07-2022)
    1.13 Billion USD
    Annual Revenue in USD
    804 Million USD
    Annual Net Income in USD
    77 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Mochida Pharmaceutical researches, develops, manufactures and sells pharmaceuticals, healthcare products and medical equipment. The company annual revenue is 102,995 million JPY and annual net income is 8,587 million JPY for year ending March 2021. The headquarters is in Japan.
  6. Grape King Bio Ltd

    World Rank (Aug-2026)
    9,520
    Market Cap (Aug-2026)
    0.942 Billion USD
    World Rank (Jan-05-2024)
    10,213
    Market Cap (Jan-05-2024)
    0.742 Billion USD
    World Rank (Jul-30-2023)
    9,459
    Market Cap (Jul-30-2023)
    0.869 Billion USD
    World Rank (Dec-25-2022)
    9,767
    Market Cap (Dec-25-2022)
    0.773 Billion USD
    World Rank (Jan-07-2022)
    10,264
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    324 Million USD
    Annual Net Income in USD
    43 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  7. KPC Pharmaceuticals

    World Rank (Aug-2026)
    9,560
    Market Cap (Aug-2026)
    0.933 Billion USD
    World Rank (Jan-05-2024)
    5,278
    Market Cap (Jan-05-2024)
    2.266 Billion USD
    World Rank (Jul-30-2023)
    5,737
    Market Cap (Jul-30-2023)
    2.005 Billion USD
    World Rank (Dec-25-2022)
    6,561
    Market Cap (Dec-25-2022)
    1.498 Billion USD
    World Rank (Jan-07-2022)
    8,078
    Market Cap (Jan-07-2022)
    1.31 Billion USD
    Headquarters Country
  8. Xvivo Perfusion AB (publ)

    World Rank (Aug-2026)
    9,566
    Market Cap (Aug-2026)
    0.932 Billion USD
    World Rank (Jan-05-2024)
    8,543
    Market Cap (Jan-05-2024)
    1.007 Billion USD
    World Rank (Jul-30-2023)
    9,414
    Market Cap (Jul-30-2023)
    0.876 Billion USD
    World Rank (Dec-25-2022)
    12,339
    Market Cap (Dec-25-2022)
    0.505 Billion USD
    World Rank (Jan-07-2022)
    10,439
    Market Cap (Jan-07-2022)
    0.83 Billion USD
    Annual Revenue in USD
    24 Million USD
    Annual Net Income in USD
    1 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Xvivo Perfusion AB (publ) is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. The company annual revenue is 179.8 million SEK and total assets are 1,150 million SEK as on 2020. The headquarters is in Sweden.
  9. Olema Pharmaceuticals Inc.

    World Rank (Aug-2026)
    9,573
    Market Cap (Aug-2026)
    0.930 Billion USD
    World Rank (Jan-05-2024)
    10,291
    Market Cap (Jan-05-2024)
    0.733 Billion USD
    World Rank (Jul-30-2023)
    15,099
    Market Cap (Jul-30-2023)
    0.343 Billion USD
    World Rank (Dec-25-2022)
    21,255
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    16,820
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -24 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
  10. Arbutus Biopharma Corporation

    World Rank (Aug-2026)
    9,596
    Market Cap (Aug-2026)
    0.924 Billion USD
    World Rank (Jan-05-2024)
    13,671
    Market Cap (Jan-05-2024)
    0.419 Billion USD
    World Rank (Jul-30-2023)
    14,777
    Market Cap (Jul-30-2023)
    0.361 Billion USD
    World Rank (Dec-25-2022)
    14,340
    Market Cap (Dec-25-2022)
    0.374 Billion USD
    World Rank (Jan-07-2022)
    13,918
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Net Income in USD
    -76 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country

Share

Ads